Why BGPT?
logo

Author Review — Check author claims against data

Compare figures, methods and claimed conclusions side‑by‑side with source data.







Press Enter ↵ to solve



    Fuel Your Discoveries




     Quick Explanation



    Author snapshot: Carlos A O de Biagi‑Junior

    Workload: small-to-moderate (7–44 papers reported across sources); citation impact variable (single high‑impact coauthorships but limited first‑author footprint in high‑impact journals). Key evidence: coauthor on a highly cited Cell Metabolism paper (2020) and first author on a BMC Genomics methods paper (2021) showing computational genomics competency




     Long Explanation



    Author Review — Carlos A O de Biagi‑Junior

    Visual evidence summary

    Authorship role distribution (qualitative)

    Explanation: among the provided papers, de Biagi‑Junior appears as first author on method/software work (CeTF) and as middle/coauthor on several high‑impact collaborative papers (Cell Metabolism). That pattern often indicates strong technical contribution and collaborative breadth but limited independent senior‑author leadership in the supplied set.

    Evidence & key citations

    • High‑impact collaborative paper (Cell Metabolism 2020) where de Biagi is a contributing coauthor; the paper is highly cited and mechanistic, increasing the author's exposure to influential research teams
    • First‑author methods/software paper (BMC Genomics 2021) showing reproducible software (CeTF) and computational competence

    Assessment — strengths, weaknesses, blindspots

    • Strengths: Demonstrated computational/methods ability (published Bioconductor package), participation in high‑impact multi‑author translational research (Cell Metabolism), range across cancer and computational biology topics (papers listed include tumor profiling, immune checkpoint studies and methods)
    • Weaknesses / red flags: modest personal h‑index and small direct first‑author paper count in the limited dataset (h‑index reported as low single digits in one source), many papers are collaborative where seniority/contribution is unclear; limited independent PI‑level leadership shown in the provided list.
    • Blindspots / missing info: institutional affiliation(s) are incomplete in supplied metadata (makes assessing lab environment and supervision difficult); contribution details (author contribution statements) are needed to quantify the author's exact experimental or conceptual role; no grant/funding info provided.

    What would strengthen the author's scientific profile?

    1. Lead (first or last) reproducible studies with clearly documented author contributions and publicly available code/data (increasing independent impact).
    2. Deposit software/packages in community repositories with vignettes and sustained maintenance to increase long‑term citations and reuse.
    3. Clarify institutional affiliation(s) and link to ORCID / persistent identifier to resolve profile fragmentation across bibliographic databases.

    Source evidence used (selected)

    Confidence note: the evaluation above uses the supplied bibliographic snapshots and specific papers; conclusions about the author's independent leadership and lab‑level role remain moderate in confidence and would change with institutional records, full author contribution statements, ORCID‑linked profile, and a complete works list.



    Feedback:   

    Updated: March 14, 2026

    BGPT Author Review



    Scientific Quality

    60%

    Demonstrates tangible computational/methods skill (first‑author Bioconductor methods paper) and is coauthor on at least one very highly cited translational paper, indicating strong collaborative access and technical competence; however, limited evidence of sustained independent leadership (few clear senior/last‑author papers in provided set), modest h‑index in some sources, and fragmented profiles across databases reduce the score.



    Communication Quality

    70%

    Publications include an open, documented Bioconductor package (good reproducible communication) and contributions to multi‑author high‑visibility papers; writing appears to be adequate for methods and collaborative biological research, but broader public/outreach or standalone review articles are not evident in the provided material.



    Author Novelty

    60%

    Novelty is moderate: the CeTF package reflects useful methodological development in gene regulatory analysis; coauthorship on mechanistic translational work shows application novelty but not yet a pattern of repeatedly groundbreaking independent discoveries.



    Scientific Rigor

    60%

    Peer‑reviewed method release and participation in mechanistic, high‑impact studies suggest sound experimental and computational rigor; however, rigorous assessment of reproducibility, data/code availability across all works, and independent replication is incomplete in the supplied metadata.

     Analysis Wizard



    Preparing a reproducible script that pulls the author's publications from OpenAlex/ORCID, parses author roles, and visualizes citation and role distributions to quantify independent vs collaborative contributions.



     Science Art


    Author Review: Carlos A O De Biagi-Junior Science Art

     Science Movie



    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion








    Get Ahead With Science Insights

    Custom summaries of the latest cutting edge Science research. Every Friday. No Ads.


    My BGPT